Post Archive by Year

Reduction seen in risk for clinically important kidney outcomes and death from cardiovascular causes

Greater use of weight management treatments seen with WNP, including bariatric surgery, low-calorie meal replacement

In a recent study, donors had initial drop in eGFR after nephrectomy, followed by lesser decline per year than nondonors

Areas with high incidence of delay characterized by increased social vulnerability including SES, housing type, and transportation

From 2007 to 2019, medical burden increased from 23.5 to 26.4 percent for low-income families and from 5.4 to 6.5 percent for higher-income families

Findings seen for men and women even at high volumes of aerobic leisure-time physical activity

Findings seen for excess treatment-resistant hypertension among Black U.S. adults

Second study shows cardiovascular benefit for semaglutide, regardless of weight loss

Increased risk seen, especially for hypertensive disease; risk was apparent as early as 30 days postdelivery

Similar benefits seen for all-cause mortality and cardiovascular disease prevention